• Influenza: The Underestimated Killer
  Oxford John, UNITED KINGDOM
• Vulnerability Due to the Waning Immune System
  Grubeck-Loebenstein Beatrix, AUSTRIA
• MF59: A Unique Adjuvant with Demonstrable Benefits in the Pandemic Setting
  Nicholson Karl, UNITED KINGDOM
• Fluad: The Appropriate Vaccine for the Elderly
  Puig-Barbera Joan, SPAIN
• Fluad: Lessons Learnt from the Field Setting
  Del Giudice Guiseppe, ITALY

• Introduction
  Nord Carl Erik, SWEDEN
• Serious Polymicrobial Bacterial Infections: Where and How Often?
  Nathwani Dilip, UNITED KINGDOM
• Current Treatment Guidelines for Polymicrobial Infections
  Weber David, USA
• Treatment Options for Polymicrobial Infections - Is Monotherapy a Thing of the Past?
  Rossi Flavia, BRAZIL

Protecting Health - Time and Time Again
'A Symposium on the New Generation of GSK Vaccines'
Friday, June 16, 2006, 17:45 – 19:45hrs, Auditorio VIII
Sponsored by GlaxoSmithKline

• Welcome & Introduction
• Timely Protection with Combination Vaccines
  Heininger Ulrich, SWITZERLAND
• Early Protection Using 2-Dose Rotarix™ Rotavirus Vaccine
  O'Ryan Miguel, CHILE
• Expanded Protection - GlaxoSmithKline's Pneumococcal CandidateVaccine
  Leach Amanda, AUSTRALIA
• Sustained Protection Elicited by GSK's Candidate HPV 16/18 Vaccine
  Harper Dianne, USA
• Questions & Answers

• Efficacy and Potential Impact of Conjugate Pneumococcal Vaccines in the Developing World
  Cutts Felicity, THE GAMBIA
• The Role of Pneumococcal Conjugated Vaccine: The Latin American Perspective
  Arguedas Adriano, COSTA RICA
• Pneumococcal Conjugate Vaccination in Asia
  Jodar Luis, REPUBLIC OF KOREA

Monitoring Emerging Disease Outbreaks: ProMED Roundtable
Saturday, June 17, 2006, 12:30 – 14:30hrs, Auditorio III
Organized by ProMED-mail

• Combating Infectious Disease & Toxin Outbreaks, Natural & Man-made, through the Internet
  Woodall Jack, BRAZIL
• Developing a Coordinated Response to the Unexpected - The Role of the Internet and the 'Informal Sector'
  Pollack Marjorie, USA
• Evaluation of ProMED-mail as an Electronic Early Warning System for Emerging Animal
  Diseases: 1996 to 2004
  Cowen Peter, USA
• ProMED-mail's Russian-language Service in the Newly Indendent States of the Former Soviet Union
  Rakhmanova Nilufar, UZBEKISTAN

• Meningococcal Disease Epidemiology and the Introduction of Meningococcal C Conjugate Vaccines: An Australian Perspective
  Richmond Peter, AUSTRALIA
• The UK Experience with Mass Vaccination against Meningococcal C
  Borrow Ray, UNITED KINGDOM
• NeisVac-C: Clinical Summary and Latest Study Results
  Ehrlich Hartmut, AUSTRIA
• Questions & Answers

• Introduction: A Global Perspective of Epidemiology and Vaccination Programs
  Kaufhold A., ITALY
• Implementation of Haemophilus influenzae Type b Vaccination in Developing Countries
  Mulholland K., UNITED KINGDOM
• Practical Concerns Matter: A Daily Challenge in EPI
  Gentile A., ARGENTINA
• The Journey of a New 5-in-1 Vaccine
  Kaufhold A., ITALY
• The Added Value of Both Efficiency and Simplicity. A Case Study
  speaker from Swiss Tropical Institute (to be confirmed)

• Introduction
  Jones Peter, BELGIUM
• Importance of Antimicrobials to Animal Health and Public Health
  Vogel Lyle P., USA
• Risk Management of Antimicrobial Use in Animals
  - Regulatory, Responsible Use, Resistance Surveillance
  Dean Steve, UNITED KINGDOM
• Closing Remarks
  Jones Peter, BELGIUM